首页>投融资
Alithea
种子轮
Alithea Genomics SA is a provider of cutting-edge products and services to develop therapeutic and biomarker discoveries based on gene expression.In February 2023, Eurostars awarded €1 million to PamGene International BV, Alithea Genomics SA, and Lausanne University Hospital (CHUV) for the development of pan cancer blood test
基本信息
-
公司全称Alithea Genomics SA
-
类型RNA-seq服务、试剂盒和生物信息解决方案提供商
-
产业领域试剂/耗材、商业服务
-
公司人数15人以下
-
地址Route de la Corniche 5 StartLab Building Alanine EPALINGES VAUD 1066; CH; Telephone: +41788303139;
-
联系电话+41 788 30 3139
-
邮箱info@alitheagenomics.com
-
成立时间2020-01-01
投融资
-
2024-03-14种子轮280万瑞士法郎Novalis Biotech Acceleration
-
2024-03-14种子轮280万瑞士法郎Novalis Biotech Acceleration
-
2023-03-21未公开50万瑞士法郎Foundation for Technological Innovation
-
2023-01-17未公开100万欧元Eurostars fund
-
2023-01-17未公开100万欧元Eurostars fund
-
2022-05-24种子轮100万瑞士法郎Novalis Biotech Acceleration
-
2022-05-24种子轮100万瑞士法郎Novalis Biotech Acceleration
-
2021-03-11债权融资10万瑞士法郎Foundation for Technological Innovation
-
2021-03-11债权融资10万瑞士法郎Foundation for Technological Innovation
- 加载更多
相关投融资企业
收并购
AMI Cardiac Monitoring 是全美领先的非卧床心脏监护服务和诊断技术提供商。AMI Cardiac Monitoring 拥有 30 多年的经验，致力于通过提供准确、及时和可操作的心脏数据来提高患者的治疗效果。我们拥有最先进的诊断工具和专业的支持团队，确保医疗服务提供商能够为出现心脏问题的患者提供卓越的护理。
种子轮
Alithea Genomics SA is a provider of cutting-edge products and services to develop therapeutic and biomarker discoveries based on gene expression.In February 2023, Eurostars awarded €1 million to PamGene International BV, Alithea Genomics SA, and Lausanne University Hospital (CHUV) for the development of pan cancer blood test
未公开
Alithea Genomics SA is a provider of cutting-edge products and services to develop therapeutic and biomarker discoveries based on gene expression.In February 2023, Eurostars awarded €1 million to PamGene International BV, Alithea Genomics SA, and Lausanne University Hospital (CHUV) for the development of pan cancer blood test
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息